BEAM THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.38 USD | -1.02% |
|
-10.54% | -21.45% |
| 04/04 | Beam Therapeutics Insider Sold Shares Worth $581,617, According to a Recent SEC Filing | MT |
| 04/04 | Beam Therapeutics Insider Sold Shares Worth $734,805, According to a Recent SEC Filing | MT |
Chart calendar Beam Therapeutics Inc.
7a59221990a3decb.z1BmaVE-83jdGqqlEPnC_cvkcKUtBA70kbcEcfLydvQ._hgfLxRnvDaYY_idIoGrrIPWNc1BU0a_6ed9KMqwDLe7PhUMYXi8J5VY4w~b7bb6e10b46f8c3621bf4edef32870d5
Upcoming events on Beam Therapeutics Inc.
Past events on Beam Therapeutics Inc.
| 14/03/2024 12:05 am | Barclays Global Healthcare Conference |
| 12/03/2024 12:10 am | Leerink Partners Global Biopharma Conference |
| 06/03/2024 11:20 pm | TD Cowen Health Care Conference |
| 27/02/2024 05:00 pm | Q4 2023 Earnings Release |
| 08/02/2024 09:00 pm | Guggenheim Healthcare Talks Biotechnology Conference |
| 09/01/2024 12:45 am | JPMorgan Healthcare Conference |
| 15/11/2023 10:00 pm | Jefferies London Healthcare Conference |
| 08/11/2023 05:00 pm | Q3 2023 Earnings Release |
| 25/10/2023 | European Society of Gene & Cell Therapy Congress |
| 26/09/2023 07:30 pm | BMO BioPharma Virtual Spotlight Series |
| 07/09/2023 07:45 pm | Wells Fargo Healthcare Conference |
| 07/09/2023 06:20 pm | Citi BioPharma Conference |
| 08/08/2023 04:00 pm | Q2 2023 Earnings Release |
| 06/06/2023 09:00 pm | Annual General Meeting |
| 30/05/2023 07:50 pm | Stifel Tailoring Genes Genetic Medicines Day |
| 24/05/2023 08:35 pm | Barclays Gene Editing and Gene Therapy Summit |
| 20/05/2023 05:00 am | American Society of Gene Cell Therapy Meeting |
| 20/05/2023 12:30 am | American Society of Gene Cell Therapy Meeting |
| 17/05/2023 08:30 pm | RBC Global Healthcare Conference - Fireside Chat |
| 10/05/2023 04:00 pm | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,02 0,00 350% | 0,02 0,01 84.62% | 51,8 12,5 316.19% | 60,9 54,2 12.37% | 378 93,7 303.31% | 63,4 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -385 -383 -0.64% | -324 -332 2.22% | -156 -398 60.67% | -431 |
|
EBIT Million USD | Released Forecast Spread | -75,2 -68,9 -9.08% | -133 -128 -3.46% | -392 -387 -1.31% | -338 -336 -0.61% | -176 -409 56.84% | -465 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -78,3 -71,5 -9.47% | -195 -132 -47.44% | -371 -369 -0.42% | -260 -322 19.27% | -131 -356 63.12% | -457 |
|
Net income Million USD | Released Forecast Spread | -91,0 -74,3 -22.56% | -196 -134 -45.63% | -371 -367 -0.92% | -289 -337 14.25% | -133 -337 60.65% | -452 |
|
EPS USD | Released Forecast Spread | -2,49 -2,29 -8.46% | -4,19 -2,94 -42.3% | -5,77 -5,80 0.59% | -4,13 -4,85 14.77% | -1,72 -4,37 60.66% | -5,44 |
| Announcement Date | 30/03/20 | 15/03/21 | 28/02/22 | 28/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 51,1 9,64 429.6% | 8,43 44,2 -80.9% | 16,7 9,44 76.43% | 15,8 7,15 120.95% | 20,0 12,7 57.35% | 24,2 15,6 54.78% | 20,1 16,8 19.41% | 17,2 23,9 -28.04% | 316 33,7 839.01% | 14,7 | 14,7 | 14,8 | 14,8 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -60,9 -71,6 14.96% | -72,9 -210 65.36% | -87,8 -70,1 -25.29% | -85,0 -95,2 10.69% | -97,3 -71,8 -35.49% | -103 -87,2 -18.26% | 138 -97,7 241.43% | -109 | -110 | -111 | -112 | |||
|
EBIT Million USD | Released Forecast Spread | -63,5 -62,4 -1.69% | -76,2 -57,8 -31.83% | -82,0 -74,9 -9.37% | -91,3 -91,8 0.59% | -89,0 -94,7 6.03% | -98,9 -95,3 -3.8% | -102 -106 3.68% | -108 -109 0.55% | 133 -108 222.95% | -124 | -124 | -122 | -125 | -115 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -64,7 -59,4 -8.97% | -69,2 -25,5 -171.86% | -72,0 -76,3 5.69% | -81,7 -93,8 12.94% | -37,3 -99,4 62.43% | -96,5 -94,1 -2.52% | -82,8 -109 23.84% | -96,1 -106 9.03% | 144 -78,3 284.23% | -121 | -117 | -117 | -121 | -114 |
|
Net income Million USD | Released Forecast Spread | -64,7 -61,4 -5.32% | -69,2 -34,3 -101.81% | -72,0 -73,4 1.95% | -110 -90,8 -20.63% | -38,3 -95,4 59.81% | -96,5 -93,0 -3.67% | -82,8 -103 19.79% | -96,1 -97,1 1.08% | 143 -57,5 348.41% | -119 | -115 | -115 | -119 | -114 |
|
EPS USD | Released Forecast Spread | -0,95 -0,95 -0.31% | -1,01 -0,89 -13.61% | -1,02 -0,97 -4.94% | -1,56 -1,30 -19.76% | -0,54 -1,35 59.93% | -1,33 -1,33 -0.36% | -1,08 -1,39 22.27% | -1,22 -1,25 2.47% | 1,73 -0,81 314.15% | -1,44 | -1,39 | -1,38 | -1,40 | -1,35 |
| Announcement Date | 28/02/22 | 09/05/22 | 09/08/22 | 07/11/22 | 28/02/23 | 10/05/23 | 08/08/23 | 08/11/23 | 27/02/24 | - | - | - | - | - |
More events
Past sector events for Beam Therapeutics Inc.
| Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 26/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 04:30 pm | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 11:30 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BEAM Stock
- Calendar Beam Therapeutics Inc.
